{"PubmedBookArticle": [], "PubmedArticle": [{"MedlineCitation": {"KeywordList": [["antimicrobial", "drug delivery systems", "fluticasone", "molecular dynamics", "molecular modeling", "nanoparticles"]], "SpaceFlightMission": [], "InvestigatorList": [], "OtherAbstract": [], "OtherID": [], "CitationSubset": ["IM"], "GeneralNote": [], "PMID": "29440875", "DateCompleted": {"Year": "2018", "Month": "09", "Day": "04"}, "DateRevised": {"Year": "2023", "Month": "11", "Day": "12"}, "Article": {"ArticleDate": [{"Year": "2018", "Month": "02", "Day": "05"}], "Language": ["eng"], "ELocationID": ["10.2147/DDDT.S148912"], "Journal": {"ISSN": "1177-8881", "JournalIssue": {"Volume": "12", "PubDate": {"Year": "2018"}}, "Title": "Drug design, development and therapy", "ISOAbbreviation": "Drug Des Devel Ther"}, "ArticleTitle": "Experimental and molecular modeling approach to optimize suitable polymers for fabrication of stable fluticasone nanoparticles with enhanced dissolution and antimicrobial activity.", "Pagination": {"StartPage": "255", "EndPage": "269", "MedlinePgn": "255-269"}, "Abstract": {"AbstractText": ["The challenges with current antimicrobial drug therapy and resistance remain a significant global health threat. Nanodrug delivery systems are playing a crucial role in overcoming these challenges and open new avenues for effective antimicrobial therapy. While fluticasone (FLU), a poorly water-soluble corticosteroid, has been reported to have potential antimicrobial activity, approaches to optimize its dissolution profile and antimicrobial activity are lacking in the literature. This study aimed to combine an experimental study with molecular modeling to design stable FLU nanopolymeric particles with enhanced dissolution rates and antimicrobial activity.", "Six different polymers were used to prepare FLU nanopolymeric particles: hydroxyl propyl methylcellulose (HPMC), poly (vinylpyrrolidone) (PVP), poly (vinyl alcohol) (PVA), ethyl cellulose (EC), Eudragit (EUD), and Pluronics<sup>\u00ae</sup>. A low-energy method, nanoprecipitation, was used to prepare the polymeric nanoparticles.", "The combination of HPMC-PVP and EUD-PVP was found most effective to produce stable FLU nanoparticles, with particle sizes of 250 nm \u00b12.0 and 280 nm \u00b14.2 and polydispersity indices of 0.15 nm \u00b10.01 and 0.25 nm \u00b10.03, respectively. The molecular modeling studies endorsed the same results, showing highest polymer drug binding free energies for HPMC-PVP-FLU (-35.22 kcal/mol \u00b10.79) and EUD-PVP-FLU (-25.17 kcal/mol \u00b11.12). In addition, it was observed that Ethocel<sup>\u00ae</sup> favored a wrapping mechanism around the drug molecules rather than a linear conformation that was witnessed for other individual polymers. The stability studies conducted for 90 days demonstrated that HPMC-PVP-FLU nanoparticles stored at 2\u00b0C-8\u00b0C and 25\u00b0C were more stable. Crystallinity of the processed FLU nanoparticles was confirmed using differential scanning calorimetry, powder X-ray diffraction analysis and TEM. The Fourier transform infrared spectroscopy (FTIR) studies showed that there was no chemical interaction between the drug and chosen polymer system. The HPMC-PVP-FLU nanoparticles also showed enhanced dissolution rate (<i>P</i><0.05) compared to the unprocessed counterpart. The in vitro antibacterial studies showed that HPMC-PVP-FLU nanoparticles displayed superior effect against gram-positive bacteria compared to the unprocessed FLU and positive control."]}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Discipline of Pharmaceutical Sciences, School of Health Sciences, University of KwaZulu-Natal, Durban, South Africa."}], "LastName": "Ahmed", "ForeName": "Shaimaa", "Initials": "S"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Discipline of Pharmaceutical Sciences, School of Health Sciences, University of KwaZulu-Natal, Durban, South Africa."}], "LastName": "Govender", "ForeName": "Thirumala", "Initials": "T"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmacy, COMSATS Institute of Information Technology (CIIT), Abbotabad."}], "LastName": "Khan", "ForeName": "Inamullah", "Initials": "I"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmacy, COMSATS Institute of Information Technology (CIIT), Abbotabad."}], "LastName": "Rehman", "ForeName": "Nisar Ur", "Initials": "NU"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmacy, COMSATS Institute of Information Technology (CIIT), Abbotabad."}], "LastName": "Ali", "ForeName": "Waqar", "Initials": "W"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmacy, Sarhad University of Science and Technology, Peshawar."}], "LastName": "Shah", "ForeName": "Syed Muhammad Hassan", "Initials": "SMH"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmacy, University of Malakand Dir (Lower), Chakdara, Khyber Pakhtunkhwa, Pakistan."}], "LastName": "Khan", "ForeName": "Shahzeb", "Initials": "S"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmaceutics, Faculty of Pharmacy, Universiti Teknologi Mara, Puncak Alam, Selangor, Malaysia."}], "LastName": "Hussain", "ForeName": "Zahid", "Initials": "Z"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmacognosy and Medicinal, Aromatic & Poisonous Plants Research Center (MAPPRC), College of Pharmacy, King Saud University, Riyadh, Saudi Arabia."}, {"Identifier": [], "Affiliation": "Department of Chemistry, Government College Ara Khel FR, Kohat, Khyber Pakhtunkhwa, Pakistan."}], "LastName": "Ullah", "ForeName": "Riaz", "Initials": "R"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmacognosy and Medicinal, Aromatic & Poisonous Plants Research Center (MAPPRC), College of Pharmacy, King Saud University, Riyadh, Saudi Arabia."}], "LastName": "Alsaid", "ForeName": "Mansour S", "Initials": "MS"}], "PublicationTypeList": ["Comparative Study", "Journal Article"]}, "MedlineJournalInfo": {"Country": "New Zealand", "MedlineTA": "Drug Des Devel Ther", "NlmUniqueID": "101475745", "ISSNLinking": "1177-8881"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Anti-Bacterial Agents"}, {"RegistryNumber": "0", "NameOfSubstance": "Drug Carriers"}, {"RegistryNumber": "0", "NameOfSubstance": "Polymers"}, {"RegistryNumber": "0", "NameOfSubstance": "Polymethacrylic Acids"}, {"RegistryNumber": "25086-15-1", "NameOfSubstance": "methylmethacrylate-methacrylic acid copolymer"}, {"RegistryNumber": "3NXW29V3WO", "NameOfSubstance": "Hypromellose Derivatives"}, {"RegistryNumber": "CUT2W21N7U", "NameOfSubstance": "Fluticasone"}, {"RegistryNumber": "FZ989GH94E", "NameOfSubstance": "Povidone"}], "MeshHeadingList": [{"QualifierName": ["chemistry", "pharmacology"], "DescriptorName": "Anti-Bacterial Agents"}, {"QualifierName": [], "DescriptorName": "Crystallization"}, {"QualifierName": [], "DescriptorName": "Drug Carriers"}, {"QualifierName": [], "DescriptorName": "Drug Compounding"}, {"QualifierName": [], "DescriptorName": "Drug Liberation"}, {"QualifierName": [], "DescriptorName": "Drug Stability"}, {"QualifierName": ["chemistry", "pharmacology"], "DescriptorName": "Fluticasone"}, {"QualifierName": ["chemistry"], "DescriptorName": "Hypromellose Derivatives"}, {"QualifierName": [], "DescriptorName": "Molecular Docking Simulation"}, {"QualifierName": [], "DescriptorName": "Molecular Dynamics Simulation"}, {"QualifierName": [], "DescriptorName": "Molecular Structure"}, {"QualifierName": [], "DescriptorName": "Nanomedicine"}, {"QualifierName": [], "DescriptorName": "Nanoparticles"}, {"QualifierName": ["chemistry"], "DescriptorName": "Polymers"}, {"QualifierName": ["chemistry"], "DescriptorName": "Polymethacrylic Acids"}, {"QualifierName": ["chemistry"], "DescriptorName": "Povidone"}, {"QualifierName": [], "DescriptorName": "Solubility"}, {"QualifierName": ["methods"], "DescriptorName": "Technology, Pharmaceutical"}], "CoiStatement": "Disclosure The authors report no conflicts of interest in this work."}, "PubmedData": {"ReferenceList": [{"ReferenceList": [], "Reference": [{"Citation": "Kawabata Y, Wada K, Nakatani M, Yamada S, Onoue S. Formulation design for poorly water-soluble drugs based on biopharmaceutics classification system: basic approaches and practical applications. Int J Pharm. 2011;420(1):1\u201310.", "ArticleIdList": ["21884771"]}, {"Citation": "Savjani KT, Gajjar AK, Savjani JK. Drug solubility: importance and enhancement techniques. ISRN Pharm. 2012;2012:195727.", "ArticleIdList": ["PMC3399483", "22830056"]}, {"Citation": "Costa P, Sousa Lobo JM. Modeling and comparison of dissolution profiles. Eur J Pharm Sci. 2001;13(2):123\u2013133.", "ArticleIdList": ["11297896"]}, {"Citation": "Hu J, Johnston KP, Williams RO. Nanoparticle engineering processes for enhancing the dissolution rates of poorly water soluble drugs. Drug Dev Ind Pharm. 2004;30(3):233\u2013245.", "ArticleIdList": ["15109023"]}, {"Citation": "McKay LI, Cidlowski JA, webpage on the Internet  Corticosteroids in the Treatment of Neoplasms. 2003.  [Accessed June 29, 2017].  Available from:  https://www.ncbi.nlm.nih.gov/books/NBK13383/"}, {"Citation": "Coutinho AE, Chapman KE. The anti-inflammatory and immunosuppressive effects of glucocorticoids, recent developments and mechanistic insights. Mol Cell Endocrinol. 2011;335(1):2\u201313.", "ArticleIdList": ["PMC3047790", "20398732"]}, {"Citation": "Wood AJJ, Barnes PJ. Inhaled glucocorticoids for asthma. N Engl J Med. 1995;332(13):868\u2013875.", "ArticleIdList": ["7870143"]}, {"Citation": "Roeder A, Schaller M, Sch\u00e4fer-Korting M, Korting HC. Safety and efficacy of fluticasone propionate in the topical treatment of skin diseases. Skin Pharmacol Physiol. 2004;18(1):3\u201311.", "ArticleIdList": ["15608497"]}, {"Citation": "de Kaski MC, Peters AM, Lavender JP, Hodgson HJ. Fluticasone propionate in Crohn\u2019s disease. Gut. 1991;32(6):657\u2013661.", "ArticleIdList": ["PMC1378883", "2060874"]}, {"Citation": "Angus P, Snook JA, Reid M, Jewell DP. Oral fluticasone propionate in active distal ulcerative colitis. Gut. 1992;33(5):711\u2013714.", "ArticleIdList": ["PMC1379308", "1612492"]}, {"Citation": "Alexander JA, Katzka DA. Therapeutic options for eosinophilic esophagitis. Gastroenterol Hepatol (N Y) 2011;7(1):59\u201361.", "ArticleIdList": ["PMC3038320", "21346856"]}, {"Citation": "Philip L, Agbay R, Samantha C. In vitro antibacterial activity of mometasone furoate, fluticasone propionate and fluticasone furoate nasal preparations against Streptococcus pneumoniae, Haemophilus influenzae, Streptococcus viridians, Staphylococcus aureus, Pseudomonas aeruginosa, and E. Philipp J Otolaryngol Head Neck Surg. 2010;25:13\u201316."}, {"Citation": "Chernuskiy VG, Govalenkova OL, Letyago GV. A concomitant antimicrobial activity of methylated and halogenated glucocorticosteroids against microorganisms isolated from the sputum of children with bronchial asthma. J V N Karazin Kharkiv Natl Univ Ser Med. 2015;29:22\u201326."}, {"Citation": "Shahani SR, Jerajani HR, Sharma K, Cooverji ND. Comparative biorelease study of fluticasone in combination with antibacterial (Neomycin) and or antifungal (coltrimazol, miconazole) agents by histamine percutaneous reaction method in healthy volunteers. Indian J Dermatol Venereol Leprol. 2017;63(3):173\u2013177.", "ArticleIdList": ["20944315"]}, {"Citation": "Feng S-S, Chien S. Chemotherapeutic engineering: application and further development of chemical engineering principles for chemotherapy of cancer and other diseases. Chem Eng Sci. 2003;58(18):4087\u20134114."}, {"Citation": "Feng S-S. New-concept chemotherapy by nanoparticles of biodegradable polymers: where are we now? Nanomedicine. 2006;1(3):297\u2013309.", "ArticleIdList": ["17716160"]}, {"Citation": "Feng SS. Nonoparticles of biodegradable polymers for new-concept chemotherapy. Expert Rev Med Devices. 2004;1(1):115\u2013125.", "ArticleIdList": ["16293015"]}, {"Citation": "Ammar HO, Salama HA, Ghorab M, Mahmoud AA. Implication of inclusion complexation of glimepiride in cyclodextrin-polymer systems on its dissolution, stability and therapeutic efficacy. Int J Pharm. 2006;320(1\u20132):53\u201357.", "ArticleIdList": ["16701974"]}, {"Citation": "Kim H, Kim Y, Lee J. Liposomal formulations for enhanced lymphatic delivery. Asian J Pharm Sci. 2013;8(2):100\u2013109."}, {"Citation": "Gu\u00e9ritte-Voegelein F, Gu\u00e9nard D, Lavelle F, Le Goff MT, Mangatal L, Potier P. Relationships between the structure of taxol analogues and their antimitotic activity. J Med Chem. 1991;34(3):992\u2013998.", "ArticleIdList": ["1672159"]}, {"Citation": "Bikiaris D, Papageorgiou GZ, Stergiou A, et al. Physicochemical studies on solid dispersions of poorly water-soluble drugs: evaluation of capabilities and limitations of thermal analysis techniques. Thermochim Acta. 2005;439(1\u20132):58\u201367."}, {"Citation": "Leuner C, Dressman J. Improving drug solubility for oral delivery using solid dispersions. Eur J Pharm Biopharm. 2000;50(1):47\u201360.", "ArticleIdList": ["10840192"]}, {"Citation": "Vasconcelos T, Sarmento B, Costa P. Solid dispersions as strategy to improve oral bioavailability of poor water soluble drugs. Drug Discov Today. 2007;12(23\u201324):1068\u20131075.", "ArticleIdList": ["18061887"]}, {"Citation": "Martinez LR, Han G, Chacko M, et al. Antimicrobial and healing efficacy of sustained release nitric oxide nanoparticles against Staphylococcus aureus skin infection. J Invest Dermatol. 2009;129(10):2463\u20132469.", "ArticleIdList": ["19387479"]}, {"Citation": "Rahman A, Husain SR, Siddiqui J, et al. Liposome-mediated modulation of multidrug resistance in human HL-60 leukemia cells. J Natl Cancer Inst. 1992;84(24):1909\u20131915.", "ArticleIdList": ["1361008"]}, {"Citation": "Riganti C, Voena C, Kopecka J, et al. Liposome-encapsulated doxorubicin reverses drug resistance by inhibiting P-glycoprotein in human cancer cells. Mol Pharm. 2011;8(3):683\u2013700.", "ArticleIdList": ["21491921"]}, {"Citation": "Kilchrist KV, Evans BC, Brophy CM, Duvall CL. Mechanism of enhanced cellular uptake and cytosolic retention of MK2 inhibitory peptide nano-polyplexes. Cell Mol Bioeng. 2016;9(3):368\u2013381.", "ArticleIdList": ["PMC5089375", "27818713"]}, {"Citation": "Zheng C, Xu J, Yao X, Xu J, Qiu L. Polyphosphazene nanoparticles for cytoplasmic release of doxorubicin with improved cytotoxicity against Dox-resistant tumor cells. J Colloid Interface Sci. 2011;355(2):374\u2013382.", "ArticleIdList": ["21220138"]}, {"Citation": "Duchene D, Cavalli R, Gref R. Cyclodextrin-based polymeric nanoparticles as efficient carriers for anticancer drugs. Curr Pharm Biotechnol. 2016;17(3):248\u2013255.", "ArticleIdList": ["26517333"]}, {"Citation": "Feng X, Vo A, Patil H, et al. The effects of polymer carrier, hot melt extrusion process and downstream processing parameters on the moisture sorption properties of amorphous solid dispersions. J Pharm Pharmacol. 2016;68(5):692\u2013704.", "ArticleIdList": ["PMC5612492", "26589107"]}, {"Citation": "El-Gendy N, Pornputtapitak W, Berkland C. Nanoparticle agglomerates of fluticasone propionate in combination with albuterol sulfate as dry powder aerosols. Eur J Pharm Sci. 2011;44(4):522\u2013533.", "ArticleIdList": ["PMC4582680", "21964203"]}, {"Citation": "Ali R, Mittal G, Ali R, et al. Development, characterisation and pharmacoscintigraphic evaluation of nano-fluticasone propionate dry powder inhalation as potential antidote against inhaled toxic gases. J Microencapsul. 2013;30(6):546\u2013558.", "ArticleIdList": ["23379507"]}, {"Citation": "Dai J, Ruan B, Zhu Y, Liang X, Su F, Su W. Preparation of nanosized Fluticasone Propionate nasal spray with improved stability and uniformity. Chem Ind Chem Eng Q. 2015;21(3):457\u2013464."}, {"Citation": "Doktorovov\u00e1 S, Ara\u00fajo J, Garcia ML, Rakovsk\u00fd E, Souto EB. Formulating fluticasone propionate in novel PEG-containing nanostructured lipid carriers (PEG-NLC) Colloids Surf B Biointerfaces. 2010;75(2):538\u2013542.", "ArticleIdList": ["19879736"]}, {"Citation": "Kadajji VG, Betageri GV. Water soluble polymers for pharmaceutical applications. Polymers (Basel) 2011;3(4):1972\u20132009."}, {"Citation": "Ahmed S, Vepuri SB, Jadhav M, Kalhapure RS, Govender T. Identifying the interaction of vancomycin with novel pH-responsive lipids as antibacterial biomaterials via accelerated molecular dynamics and binding free energy calculations. Cell Biochem Biophys. 2017 Mar;:9. Epub.", "ArticleIdList": ["28281230"]}, {"Citation": "Ubrich N, Schmidt C, Bodmeier R, Hoffman M, Maincent P. Oral evaluation in rabbits of cyclosporin-loaded Eudragit RS or RL nanoparticles. Int J Pharm. 2005;288(1):169\u2013175.", "ArticleIdList": ["15607269"]}, {"Citation": "Yen FL, Wu TH, Lin LT, Cham TM, Lin CC. Naringenin-loaded nanoparticles improve the physicochemical properties and the hepatoprotective effects of naringenin in orally-administered rats with CCl4-induced acute liver failure. Pharm Res. 2009;26(4):893\u2013902.", "ArticleIdList": ["19034626"]}, {"Citation": "Zili Z, Sfar S, Fessi H. Preparation and characterization of poly-epsilon-caprolactone nanoparticles containing griseofulvin. Int J Pharm. 2005;294(1\u20132):261\u2013267.", "ArticleIdList": ["15814249"]}, {"Citation": "Ravikumara NR, Madhusudhan B, Nagaraj TS, Hiremat SR, Raina G. Preparation and evaluation of nimesulide-loaded ethylcellulose and methylcellulose nanoparticles and microparticles for oral delivery. J Biomater Appl. 2009;24(1):47\u201364.", "ArticleIdList": ["19386664"]}, {"Citation": "Suthar AK, Solanki SS, Dhanwani RK. Enhancement of dissolution of poorly water soluble raloxifene hydrochloride by preparing nanoparticles. J Adv Pharm Educ Res. 2011;2:189\u2013194."}, {"Citation": "Bilati U, All\u00e9mann E, Doelker E. Development of a nanoprecipitation method intended for the entrapment of hydrophilic drugs into nanoparticles. Eur J Pharm Sci. 2005;24(1):67\u201375.", "ArticleIdList": ["15626579"]}, {"Citation": "Shah SMH, Ullah F, Khan S, et al. Smart nanocrystals of artemether: fabrication, characterization, and comparative in vitro and in vivo antimalarial evaluation. Drug Des Devel Ther. 2016;10:3837\u20133850.", "ArticleIdList": ["PMC5125812", "27920499"]}, {"Citation": "Appalasamy S, Lo KY, Ch\u2019Ng SJ, Nornadia K, Othman AS, Chan LK. Antimicrobial activity of artemisinin and precursor derived from in vitro plantlets of Artemisia annua L. Biomed Res Int. 2014;2014:215872.", "ArticleIdList": ["PMC3915762", "24575401"]}, {"Citation": "DeLano WL, homepage on the Internet  . The PyMOL Molecular Graphics System. Schr\u00f6dinger LLC; 2002.  [Accessed November 25, 2017].  Version 1. Available from:  http://www.pymol.org."}, {"Citation": "Olsen L, Samavati FF, Sousa MC, Jorge JA. Sketch-based modeling: a survey. Comput Graph. 2009;33(1):85\u2013103."}, {"Citation": "Trott O, Olson AJ. AutoDock Vina. J Comput Chem. 2010;31:445\u2013461.", "ArticleIdList": ["PMC3041641", "19499576"]}, {"Citation": "Goddard TD, Huang CC, Ferrin TE. Visualizing density maps with UCSF Chimera. J Struct Biol. 2007;157(1):281\u2013287.", "ArticleIdList": ["16963278"]}, {"Citation": "Case DA, Cheatham TE, Darden T, et al. The Amber biomolecular simulation programs. J Comput Chem. 2005;26(16):1668\u20131688.", "ArticleIdList": ["PMC1989667", "16200636"]}, {"Citation": "Fox T, Kollman PA. Application of the RESP methodology in the parametrization of organic solvents. J Phys Chem B. 1998;102(41):8070\u20138079."}, {"Citation": "Frisch MJ, Trucks GW, Schlegel HB, et al. Gaussian 09. Wallingford, CT: Gaussian, Inc; 2009. pp. 2\u20133."}, {"Citation": "Jorgensen WL, Chandrasekhar J, Madura JD, Impey RW, Klein ML. Comparison of simple potential functions for simulating liquid water. J Chem Phys. 1983;79(2):926."}, {"Citation": "Harvey MJ, De Fabritiis G. An implementation of the smooth particle mesh Ewald method on GPU hardware. J Chem Theory Comput. 2009;5(9):2371\u20132377.", "ArticleIdList": ["26616618"]}, {"Citation": "Ryckaert J-P, Ciccotti G, Berendsen HJC. Numerical integration of the cartesian equations of motion of a system with constraints: molecular dynamics of n-alkanes. J Comput Phys. 1977;23(3):327\u2013341."}, {"Citation": "Pettersen EF, Goddard TD, Huang CC, et al. UCSF Chimera \u2013 a visualization system for exploratory research and analysis. J Comput Chem. 2004;25(13):1605\u20131612.", "ArticleIdList": ["15264254"]}, {"Citation": "Humphrey W, Dalke A, Schulten K. VMD: visual molecular dynamics. J Mol Graph. 1996;14(1):27\u201338.", "ArticleIdList": ["8744570"]}, {"Citation": "Laskowski RA, Swindells MB. LigPlot+: multiple ligand-protein interaction diagrams for drug discovery. J Chem Inf Model. 2011;51(10):2778\u20132786.", "ArticleIdList": ["21919503"]}, {"Citation": "Schrodinger LLC. The PyMOL Molecular Graphics System, Version 18. 2015.  [Accessed January 3, 2017].  Available from:  https://pymol.org/2/support.html."}, {"Citation": "Homeyer N, Gohlke H. FEW: a workflow tool for free energy calculations of ligand binding. J Comput Chem. 2013;34(11):965\u2013973.", "ArticleIdList": ["23288722"]}, {"Citation": "Srinivasan J, Cheatham TE, Cieplak P, Kollman PA, Case DA. Continuum solvent studies of the stability of DNA, RNA, and phosphoramidate \u2013 DNA helices. J Am Chem Soc. 1998;120(37):9401\u20139409."}, {"Citation": "Godschalk F, Genheden S, S\u00f6derhjelm P, Ryde U. Comparison of MM/ GBSA calculations based on explicit and implicit solvent simulations. Phys Chem Chem Phys. 2013;15(20):7731\u20137739.", "ArticleIdList": ["23595060"]}, {"Citation": "Foloppe N, Hubbard R. Towards predictive ligand design with free-energy based computational methods? Curr Med Chem. 2006;13(29):3583\u20133608.", "ArticleIdList": ["17168725"]}, {"Citation": "Hou T, Wang J, Li Y, et al. Assessing the performance of the MM/ PBSA and MM/GBSA methods: I. The accuracy of binding free energy calculations based on molecular dynamics simulations. J Chem Inf Comput Sci. 2011;51(1):69\u201382.", "ArticleIdList": ["PMC3029230", "21117705"]}, {"Citation": "Wu L, Zhang J, Watanabe W. Physical and chemical stability of drug nanoparticles. Adv Drug Deliv Rev. 2011;63(6):456\u2013469.", "ArticleIdList": ["21315781"]}, {"Citation": "Patravale VB, Date AA, Kulkarni RM. Nanosuspensions: a promising drug delivery strategy. J Pharm Pharmacol. 2004;56(7):827\u2013840.", "ArticleIdList": ["15233860"]}, {"Citation": "ter Horst JH, Geertman RM, van Rosmalen GM. The effect of solvent on crystal morphology. J Cryst Growth. 2001;230(1\u20132):277\u2013284."}, {"Citation": "Khan S, de Matas M, Zhang J, Anwar J. Nanocrystal preparation: low-energy precipitation method revisited. Cryst Growth Des. 2013;13(7):2766\u20132777."}, {"Citation": "Bunjes H, Koch MHJ, Westesen K. Effect of Particle Size on Colloidal Solid Triglycerides. Hamburg, Germany: Langmuir; 2000."}, {"Citation": "Valleri M, Mura P, Maestrelli F, Cirri M, Ballerini R. Development and evaluation of glyburide fast dissolving tablets using solid dispersion technique. Drug Dev Ind Pharm. 2004;30(5):525\u2013534.", "ArticleIdList": ["15244088"]}, {"Citation": "Lin D, Huang Y. A thermal analysis method to predict the complete phase diagram of drug-polymer solid dispersions. Int J Pharm. 2010;399(1\u20132):109\u2013115.", "ArticleIdList": ["20727391"]}, {"Citation": "Liu X, Lu M, Guo Z, Huang L, Feng X, Wu C. Improving the chemical stability of amorphous solid dispersion with cocrystal technique by hot melt extrusion. Pharm Res. 2012;29(3):806\u2013817.", "ArticleIdList": ["22009589"]}, {"Citation": "O\u2019Mahony M, Leung AK, Ferguson S, Trout BL, Myerson AS. A process for the formation of nanocrystals of active pharmaceutical ingredients with poor aqueous solubility in a nanoporous substrate. Org Process Res Dev. 2015;19(9):1109\u20131118."}, {"Citation": "Ali HR, Edwards HG, Kendrick J, Scowen IJ. Vibrational spectroscopic study of fluticasone propionate. Spectrochim Acta A Mol Biomol Spectrosc. 2009;72(2):244\u2013247.", "ArticleIdList": ["19095495"]}, {"Citation": "Sun TM, Du JZ, Yan LF, Mao HQ, Wang J. Self-assembled biodegradable micellar nanoparticles of amphiphilic and cationic block copolymer for siRNA delivery. Biomaterials. 2008;29(32):4348\u20134355.", "ArticleIdList": ["18715636"]}, {"Citation": "Verma S, Kumar S, Gokhale R, Burgess DJ. Physical stability of nanosuspensions: Investigation of the role of stabilizers on Ostwald ripening. Int J Pharm. 2011;406(1\u20132):145\u2013152.", "ArticleIdList": ["21185926"]}, {"Citation": "Rabinow BE. Nanosuspensions in drug delivery. Nat Rev Drug Discov. 2004;3(9):785\u2013796.", "ArticleIdList": ["15340388"]}, {"Citation": "Voorhees PW. The theory of Ostwald ripening. J Stat Phys. 1985;38(1\u20132):231\u2013252."}, {"Citation": "Dalvi SV, Dave RN. Analysis of nucleation kinetics of poorly water-soluble drugs in presence of ultrasound and hydroxypropyl methyl cellulose during antisolvent precipitation. Int J Pharm. 2010;387(1\u20132):172\u2013179.", "ArticleIdList": ["20026199"]}, {"Citation": "Anwar J, Khan S, Lindfors L. Secondary crystal nucleation: nuclei breeding factory uncovered. Angew Chem Int Ed Engl. 2015;54(49):14681\u201314684.", "ArticleIdList": ["25809644"]}, {"Citation": "Afifi SA, Hassan MA, Abdelhameed AS, Elkhodairy KA. Nanosuspension: an emerging trend for bioavailability enhancement of etodolac. Int J Polym Sci. 2015;2015:1\u201316."}, {"Citation": "Freitas C, M\u00fcller RH. Effect of light and temperature on zeta potential and physical stability in solid lipid nanoparticle (SLN\u2122) dispersions. Int J Pharm. 1998;168(2):221\u2013229."}, {"Citation": "Seedat N, Kalhapure RS, Mocktar C, et al. Co-encapsulation of multi-lipids and polymers enhances the performance of vancomycin in lipid\u2013 polymer hybrid nanoparticles: in vitro and in silico studies. Mater Sci Eng C. 2016;61:616\u2013630.", "ArticleIdList": ["26838890"]}, {"Citation": "Lambert PA. Cellular impermeability and uptake of biocides and antibiotics in Gram-positive bacteria and mycobacteria. J Appl Microbiol. 2002;92(s1):46S\u201354S.", "ArticleIdList": ["12000612"]}, {"Citation": "Singh R, Lillard JW. Nanoparticle-based targeted drug delivery. Exp Mol Pathol. 2009;86(3):215\u2013223.", "ArticleIdList": ["PMC3249419", "19186176"]}]}], "History": [{"Year": "2018", "Month": "2", "Day": "15", "Hour": "6", "Minute": "0"}, {"Year": "2018", "Month": "2", "Day": "15", "Hour": "6", "Minute": "0"}, {"Year": "2018", "Month": "9", "Day": "5", "Hour": "6", "Minute": "0"}, {"Year": "2018", "Month": "2", "Day": "5"}], "PublicationStatus": "epublish", "ArticleIdList": ["29440875", "PMC5804124", "10.2147/DDDT.S148912", "dddt-12-255"]}}]}